MyFinsight
Home
Blog
About
CONMED Corp (CNMD)
CONMED Corp (CNMD)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
$2,298K
Free Cash flow
$34,161K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from term loan
Proceeds from revolving line of ...
Proceeds from sale of product of...
Others
Negative Cash Flow Breakdown
Payments to repurchase convertib...
Payments on revolving line of cr...
Payments related to contingent c...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income
23,071
13,828
16,739
30,316
Depreciation
4,079
4,174
4,066
13,077
Amortization of deferred debt issuance costs
1,054
1,276
1,539
4,107
Amortization
14,967
14,663
14,784
42,354
Stock-based compensation
5,230
5,502
4,971
23,352
Deferred income taxes
2,148
1,535
812
2,711
Gain on sale of a product line
-
-3,916
-
-
Gain on sale of product offerings, net
-1,512
-
-
-
Non-cash adjustments to fair value of contingent consideration liability
-112
722
19,447
3,504
Loss on early extinguishment of debt
-
-
0
363
(gain) loss on early extinguishment of debt, net
4,597
-
-
-
Accounts receivable
11,351
-18,606
22,671
-20,310
Inventories
1,437
12,269
-8,509
15,242
Accounts payable
-4,248
10,480
-13,612
3,863
Income taxes
-
-
-558
-
Accrued compensation and benefits
9,447
-21,153
5,923
8,990
Other assets
-532
17,215
225
12,934
Other liabilities
-4,092
-2,761
6,611
-417
Net cash provided by operating activities
37,095
13,472
46,335
124,354
Proceeds from sale of a product line
-
-7,000
-
-
Proceeds from sale of product offerings
-21,500
-
-
-
Purchases of property, plant and equipment
2,934
2,892
5,111
14,695
Other
0
0
2,000
-850
Net cash provided by (used in) investing activities
11,566
4,108
-7,111
-13,845
Payments on term loan
0
0
20,000
79,821
Proceeds from term loan
450,000
-
0
25,234
Payments on revolving line of credit
247,000
155,000
187,000
508,432
Proceeds from revolving line of credit
415,000
180,000
187,000
508,432
Repurchases of common stock
6,204
37,017
-
-
Payments to repurchase convertible notes
637,176
-
0
0
Payments related to contingent consideration
17,489
11,364
11,183
22,577
Payments related to debt issuance costs
3,547
-
0
2,897
Dividends paid on common stock
0
0
6,191
18,555
Other, net
182
828
4
166
Net cash used in financing activities
-46,234
-22,553
-37,370
-98,450
Effect of exchange rate changes on cash and cash equivalents
-129
-814
34
2,411
Net increase (decrease) in cash and cash equivalents
2,298
-5,787
1,888
14,470
Cash and cash equivalents at beginning of period
35,030
40,817
38,929
24,459
Cash and cash equivalents at end of period
37,328
35,030
40,817
38,929
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net income
$23,071K
Amortization
$14,967K
Proceeds from sale of
product offerings
-$21,500K
Accrued compensation
and benefits
$9,447K
Stock-based compensation
$5,230K
Depreciation
$4,079K
something is missing
$3,916K
Deferred income taxes
$2,148K
Amortization of deferred debt
issuance costs
$1,054K
Other assets
-$532K
Net cash provided by
operating activities
$37,095K
Net cash provided by
(used in) investing...
$11,566K
Canceled cashflow
$27,349K
Canceled cashflow
$9,934K
Net increase
(decrease) in cash and cash...
$2,298K
Canceled cashflow
$46,363K
Accounts receivable
$11,351K
(gain) loss on early
extinguishment of debt, net
$4,597K
Accounts payable
-$4,248K
Other liabilities
-$4,092K
Gain on sale of
product offerings, net
-$1,512K
Inventories
$1,437K
Non-cash adjustments to
fair value of...
-$112K
Proceeds from term loan
$450,000K
Proceeds from revolving
line of credit
$415,000K
Other, net
$182K
something is missing
-$7,000K
Purchases of property,
plant and equipment
$2,934K
Net cash used in
financing activities
-$46,234K
Effect of exchange rate
changes on cash and cash...
-$129K
Canceled cashflow
$865,182K
Payments to repurchase
convertible notes
$637,176K
Payments on revolving
line of credit
$247,000K
Payments related to
contingent consideration
$17,489K
Repurchases of common stock
$6,204K
Payments related to debt
issuance costs
$3,547K
Buy us a coffee